about
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract ...
Read More
299.94
-5.80
(-1.90%)
473.0K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for BeiGene Ltd - ADR is on 07 Aug 2025 for the purpose of BeiGene Ltd Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
BeiGene Ltd - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..